Nabriva Therapeutics' Series A Round

Nabriva Therapeutics raised a round of funding on October 28, 2009.

Nabriva Therapeutics is a biotechnology company focused on developing a class of antibiotics, the pleuromutilins, for the treatment of patients with serious infections caused by multi-drug resistant p…

Articles about Nabriva Therapeutics' Series A Round: